BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 16952986)

  • 1. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats.
    Shigemura N; Sawa Y; Mizuno S; Ono M; Ohta M; Nakamura T; Kaneda Y; Matsuda H
    Circulation; 2005 Mar; 111(11):1407-14. PubMed ID: 15781752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated gene expression of hepatocyte growth factor prevents postoperative peritoneal adhesion in a rat model.
    Liu HJ; Wu CT; Duan HF; Wu B; Lu ZZ; Wang L
    Surgery; 2006 Sep; 140(3):441-7. PubMed ID: 16934607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
    Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
    Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.
    Hayashi K; Nakamura S; Morishita R; Moriguchi A; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2000 Oct; 7(19):1664-71. PubMed ID: 11083475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE
    Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
    Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
    Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell transplantation therapy for a rat model of secondary lymphedema.
    Kawai Y; Shiomi H; Abe H; Naka S; Kurumi Y; Tani T
    J Surg Res; 2014 Jun; 189(1):184-91. PubMed ID: 24680387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease.
    Koike H; Ishida A; Shimamura M; Mizuno S; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Dec; 13(23):1639-44. PubMed ID: 16791285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats.
    Song MB; Yu XJ; Zhu GX; Chen JF; Zhao G; Huang L
    Vascul Pharmacol; 2009; 51(2-3):205-13. PubMed ID: 19577663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies of VEGF-C gene for the treatment of chronic obstructive lymphedema in mouse tail model].
    Hu XQ; Jiang ZH; Liu NF
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 May; 24(3):207-11. PubMed ID: 18717357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.